Individuals experience sex-specific warning symptoms before impending cardiac arrest, underscoring the importance of recognizing and addressing gender-specific risk factors and symptoms in the early detection and prevention of cardiovascular events.
April 2024
Zilebesiran, an RNA interference therapeutic agent, shows promise for controlling high blood pressure with biannual injections. This novel treatment approach may offer improved blood pressure management for individuals with hypertension.
March 2024